Oxford Vacmedix Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 6

Oxford Vacmedix General Information

Description

Operator of a therapeutic agents development company, intended to deliver immunotherapy for cancer treatment. The company's therapeutic agents are vaccines for cancers and a range of infectious diseases, including tuberculosis, HPV, and Hepatitis B, thus activating the immune system to attack tumors directly, enabling physicians to significantly reduce the need for invasive treatments such as chemotherapy and radiotherapy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • The Magdalen Centre
  • The Oxford Science Park
  • Oxford OX4 4GA
  • England, United Kingdom
+44 01865
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • The Magdalen Centre
  • The Oxford Science Park
  • Oxford OX4 4GA
  • England, United Kingdom
+44 01865

Oxford Vacmedix Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oxford Vacmedix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private 01-Nov-2025 Completed Clinical Trials - Phase 1
7. Later Stage VC (Series B) 16-May-2025 Completed Clinical Trials - Phase 1
6. Grant 17-Feb-2022 Completed Clinical Trials - Phase 1
5. Grant 01-Dec-2019 Completed Clinical Trials - Phase 1
4. Later Stage VC (Series A) 06-Mar-2018 Completed Clinical Trials - Phase 1
3. Early Stage VC 01-Oct-2015 Completed Pre-Clinical Trials
2. Early Stage VC 01-Sep-2012 $629K $629K Completed Pre-Clinical Trials
1. University Spin-Out 16-Mar-2012 Completed Startup
To view Oxford Vacmedix’s complete valuation and funding history, request access »

Oxford Vacmedix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 92,716 $0.000133 $13.21 $13.21 1x $13.21 3.52%
Ordinary 95,766 $0.000133 $12.67 $12.67 1x $12.67 3.63%
To view Oxford Vacmedix’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Oxford Vacmedix Patents

Oxford Vacmedix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202510316-D0 Antibody compositions Pending 27-Jun-2025
GB-202409394-D0 Antibody compositions Inactive 28-Jun-2024
GB-202309980-D0 Antibody compositions Inactive 30-Jun-2023
GB-202210093-D0 Antibody compositions Inactive 08-Jul-2022
EP-4337322-A1 Vaccine formulation comprising recombinant overlapping peptides and native proteins Pending 11-May-2021 A61P31/12
To view Oxford Vacmedix’s complete patent history, request access »

Oxford Vacmedix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oxford Vacmedix Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Dx & Vx Corporation Minority
Proven Connect Impact Investing Minority
Innovate UK Government
Cancer Rop Co Corporation Minority
RTC Innovation Corporation Minority
You’re viewing 5 of 6 investors. Get the full list »

Oxford Vacmedix FAQs

  • When was Oxford Vacmedix founded?

    Oxford Vacmedix was founded in 2012.

  • Where is Oxford Vacmedix headquartered?

    Oxford Vacmedix is headquartered in Oxford, United Kingdom.

  • What is the size of Oxford Vacmedix?

    Oxford Vacmedix has 8 total employees.

  • What industry is Oxford Vacmedix in?

    Oxford Vacmedix’s primary industry is Drug Discovery.

  • Is Oxford Vacmedix a private or public company?

    Oxford Vacmedix is a Private company.

  • What is Oxford Vacmedix’s current revenue?

    The current revenue for Oxford Vacmedix is .

  • How much funding has Oxford Vacmedix raised over time?

    Oxford Vacmedix has raised $18M.

  • Who are Oxford Vacmedix’s investors?

    Dx & Vx, Proven Connect, Innovate UK, Cancer Rop Co, and RTC Innovation are 5 of 6 investors who have invested in Oxford Vacmedix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process